Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling

M. Wilhelm, Scott; Adnane, Lila; Newell, Philippa; Villanueva, Augusto; M. Llovet, Josep; Lynch, Mark

doi:10.1158/1535-7163.mct-08-0013

Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling | NobleBlocks